Mohamed Elsawy is a Senior Lecturer in Pharmaceutical Sciences at the Leicester School of Pharmacy and the team leader of the . Mohamed gained his PhD from School of Pharmacy at Queen’s University of Belfast in 2012 supervised by Prof Brian Walker. His PhD project focused on the design and synthesis of modified peptide analogues and peptidomimetics for targeting key protein-protein complexes implicated in cancer resistance towards intrinsic apoptosis.
Following his PhD, he was awarded a short-term postdoctoral fellowship at the University of Bordeaux, France, hosted in Prof Ivan Huc group. During his first postdoc, Mohamed developed new solid phase peptide synthesis (SPPS) strategies for the synthesis of aliphatic/aromatic oligoamide foldamers with helical conformations.
In 2014, he started a EPSRC funded postdoctoral training in the Polymers & Peptides Research Group (led by Prof Alberto Saiani & Prof Aline Miller), at the Manchester Institute of Biotechnology, University of Manchester. In Manchester, Mohamed worked on the design and development of self-assembling β-sheet forming peptide nanofibers for the fabrication of hydrogels as vehicles for controlled drug delivery and as 3D scaffolds for stem cells.
In 2017, he was appointed Lectureship in Pharmaceutics at the School of Pharmacy and Biomedical Sciences, University of Central Lancashire, where he started the PBNG. In 2020, Mohamed moved with PBNG to Leicester School of Pharmacy upon his appointment as a Senior Lecturer in Pharmaceutical Sciences. Mohamed has published numerous articles in top journals in his field (Chemistry of Materials, Biomacromolecules, Bioorganic & Medicinal Chemistry, Langmuir, Journal of Tissue Engineering…etc.) and presented in many national and international conferences.
He has supervised postgraduate research projects including PhD, MRes and MSc as well as undergraduate research projects. He also acted as a peer-reviewer for various journals and grant applications including UK Research Council funds and European funds.